Historical Stock Chart
1 Year : From Apr 2019 to Apr 2020
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conferences:
Quentin Blackford, Executive Vice President and Chief Financial Officer, and Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present at the 39th Annual Canaccord Genuity Growth Conference in Boston, MA, on Wednesday, August 7th, 2019 at 2:00 PM (ET). The presentation, which will occur live at the InterContinental Boston Hotel, will be concurrently webcast.
Quentin Blackford, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York, NY, on Monday, September 9th, 2019 at 9:55 AM (ET). The presentation, which will occur live at the Grand Hyatt New York, will be concurrently webcast.
The link to the webcast will be available on the Dexcom website at www.dexcom.com by navigating to “About Us,” then “Investor Relations,” and finally “Events and Presentations” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for use by people with diabetes and by healthcare providers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190802005092/en/
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development